The N-Of-1 Clinical Trial: The Ultimate Strategy For Individualizing Medicine?
Top Cited Papers
- 10 March 2011
- journal article
- Published by Taylor & Francis in Personalized Medicine
- Vol. 8 (2) , 161-173
Abstract
N-of-1 or single subject clinical trials consider an individual patient as the sole unit of observation in a study investigating the efficacy or side-effect profiles of different interventions. The...Keywords
Funding Information
- Price Foundation (Zurich, Switzerland) and Scripps Genomic Medicine (U19 AG023122-05, R01 MH078151-03, N01 MH22005, U01 DA024417-01, P50 MH081755-01, R01 AG030474-02, N01 MH022005, R01 HL089655-02, R01 MH080134-03, U54 CA143906-01, UL1 RR025774-03)
This publication has 75 references indexed in Scilit:
- Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerationsJournal of Clinical Epidemiology, 2010
- Using N-of-1 Trials to Improve Patient Management and Save CostsJournal of General Internal Medicine, 2010
- Opportunities for Research and NIHScience, 2010
- The Policy Debate over Public Investment in Comparative Effectiveness ResearchJournal of General Internal Medicine, 2009
- Clinically Available Pharmacogenomics TestsClinical Pharmacology & Therapeutics, 2009
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary preventionBMC Public Health, 2009
- What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the FutureThe Milbank Quarterly, 2008
- Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patientsEuropean Journal of Cancer, 2007
- Cancer genes and the pathways they controlNature Medicine, 2004